CDK12/13 inhibition in ovarian cancer cell lines

被引：0
|
作者：
Fiegl, H. [1 ]
Hovdar, L. [1 ]
Handle, F. [2 ]
Santer, F. [3 ]
Tsibulak, I [1 ]
Wieser, V [1 ]
Ausserlechner, M. J. [4 ]
Schnaiter, S. [5 ]
Zeimet, A. G. [1 ]
Marth, C. [1 ]
机构：
[1] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
[2] Med Univ Innsbruck, Inst Pathol Neuropathol & Mol Pathol, Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Urol, Innsbruck, Austria
[4] Med Univ Innsbruck, Dept Pediat 1, Innsbruck, Austria
[5] Med Univ Innsbruck, Inst Human Genet, Innsbruck, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 04期
关键词：
REPAIR;
D O I：
10.1055/s-0043-1766400
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
009
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [21] ROLE OF CDK12 IN REGULATION OF DNA DAMAGE RESPONSE IN OVARIAN CANCER CELLS
    Jaroslav, Klat
    Marta, Dzimkova
    Hana, Paculova
    Sylva, Bajsova
    Jiri, Kohoutek
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 132 - 132
  • [22] CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer
    Li, Yi
    Zhang, Hui
    Li, Qin
    Zou, Pingjin
    Huang, Xingxiang
    Wu, Chihua
    Tan, Li
    CANCER LETTERS, 2020, 495 : 12 - 21
  • [23] Combination of CDK12 inhibition and olaparib enhances genomic instability in cancer models
    Alnemy, S.
    Rajagopal, N.
    Perera, P.
    Shawgo, R.
    Dworakowski, W.
    LaPlaca, D.
    Carulli, J.
    Chuaqui, C.
    Hu, S.
    Moebius, D.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S53 - S53
  • [24] Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas
    Gao, Jing
    Wang, Michelle Y.
    Ren, Yuan
    Lwin, Tint
    Li, Tao
    Yan, Joy C.
    Sotomayor, Eduardo M.
    Duckett, Derek R.
    Shah, Bijal D.
    Shain, Kenneth H.
    Zhao, Xiaohong
    Tao, Jianguo
    HAEMATOLOGICA, 2022, 107 (05) : 1119 - 1130
  • [25] CDK12 Changes Telling in Prostate Cancer
    Caruso, Catherine
    CANCER DISCOVERY, 2018, 8 (09) : 1055 - 1056
  • [26] CDK12: a potential therapeutic target in cancer
    Emadi, Fatemeh
    Teo, Theodosia
    Rahaman, Muhammed H.
    Wang, Shudong
    DRUG DISCOVERY TODAY, 2020, 25 (12) : 2257 - 2267
  • [27] Association of encapsulation of CDK12 inhibitor with anti-tumour activity in colon cancer cell lines.
    Perez-Segura, Pedro
    Diaz-Tejeiro, Cristina
    Ocana, Alberto
    Sanvicente, Adrian
    Arenas-Moreira, Maria
    Alonso Moreno, Carlos
    Nieto Jimenez, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] CDK12: an emerging therapeutic target for cancer
    Lui, Goldie Y. L.
    Grandori, Carla
    Kemp, Christopher J.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (11) : 957 - 962
  • [29] Modeling of cell cycle response to cyclin-dependent kinase 12 (CDK12) inhibition
    Stein, S.
    Martial, L.
    Elaassaiss-Schaap, J.
    Perera, P.
    Alnemy, S.
    LaPlaca, D.
    Moebius, D.
    Hu, S.
    Dworakowski, W.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S43 - S43
  • [30] Functions of Cdk12 and Cdk13 in axonal growth and neural development
    Fann, M-J
    Chen, H-R
    Lin, G-T
    Huang, C-K
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 : 39 - 39
12345